RR Series — Research Grants

NIH R34 Grants — Planning Grant

Reviewed by Dr. Meng ZhaoLast reviewed June 9, 2026Data refreshed June 9, 2026Editorial standards

Planning for clinical trials or large-scale studies

Funding

Up to $450,000 direct costs over the project

Duration

Up to 3 years

Eligibility

Investigators planning trials

Activity code

R34

What is the NIH R34 grant?

The R34 is the NIH Planning Grant — used to support the planning phase of a clinical trial or other large research effort, ahead of a full implementation grant (e.g., U01, R01).

Recent R34 awards from NIH RePORTER

Examples of funded R34 projects across the last two fiscal years. The matching-award count comes from the full result set; funding totals, averages, rankings, and examples use the first 500 records returned by NIH RePORTER. Figures reflect a snapshot last refreshed on June 9, 2026.

Matching awards (last 2 FYs)
392
Full matching record count on RePORTER
Sampled funding
$113.3M
Sum of award amounts in the sample
Average award
$289K
Mean award amount in the sample

Example R34 projects from the sample

  • Feasibility study of a chaplain-delivered compassion intervention to improve psychological safety among interprofessional healthcare teams

    5R34AT012509-03
    Jennifer Mascaro · EMORY UNIVERSITY, GA · $273,536 · awarded Jun 5, 2026 · NIH

    Enter the text here that is the new abstract information for your application. This section must be no longer than 30 lines of text. Healthcare provider burnout is pervasive in oncology, and it imparts harm to providers and patients, increases healthcare and workforce disparities, and exacerbates projected physician and nursing shortages. Although burnout…

  • Tailoring a fun and engaging tech-assisted cognitive behavioral therapy program for adolescents and young adults with hematological malignancies: A planning grant

    5R34CA297498-02
    Adam DuVall · UNIVERSITY OF CHICAGO, IL · $332,527 · awarded Jun 3, 2026 · NIH

    Project Summary/Abstract Adolescents and young adults (AYA) with cancer face unique psychosocial challenges during their cancer journey, especially individuals diagnosed with a hematologic malignancy (HM), often resulting in clinically significant depression. While evidence-based depression treatments are available for AYAs without cancer, AYAs with cancer,…

  • An Adaptive Psychological Intervention to Improve Pain and Reduce Opioid Use following an Injury

    5R34DA060172-02
    Lisa Matero · HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES, MI · $236,548 · awarded Jun 1, 2026 · NIH

    As many as 24% of the 6.8 million patients who seek treatment for a musculoskeletal injury each year continue opioid use long-term, which can lead to negative consequences including opioid use disorders, overdose, and death. Because tapering patients off chronic opioid use is challenging, interventions are needed to assist patients in opioid cessation…

  • Harnessing Evidence-based Psychotherapies to Develop an Integrated Intervention Targeting Key Psychological Mechanisms of PTSD in Cardiac Patients

    1R34HL180396-01A1
    Jennifer Sumner · UNIVERSITY OF CALIFORNIA LOS ANGELES, CA · $236,250 · awarded May 29, 2026 · NIH

    Project Summary Sudden, life-threatening cardiac events can be terrifying experiences that can trigger the onset of posttraumatic stress disorder (PTSD). PTSD symptoms are common after cardiac events, with over 1 in 5 patients receiving implantable cardioverter defibrillators (ICDs) for prevention of life-threatening arrhythmias and sudden cardiac arrest…

  • Intelligent chatbot for online support groups to treat tobacco addiction.

    1R34DA061012-01A1
    Cornelia Pechmann · UNIVERSITY OF CALIFORNIA-IRVINE, CA · $235,500 · awarded May 28, 2026 · NIH

    PROJECT ABSTRACT We seek to refine, field test, and deploy an intelligent AI-based chatbot in small, peer-to-peer mobile support groups for smoking cessation. The chatbot will complement the human support group members by responding to posts when no human can. We expect the chatbot to improve engagement by ensuring no post goes unanswered. By developing and…

  • Caring for the Caregivers: A Community-Developed Program to Prevent Substance Use for Children with Incarcerated Parents

    1R34DA064351-01
    Cady Berkel · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ · $730,989 · awarded May 27, 2026 · NIH

    Project Summary/Abstract National estimates suggest more than five million children in the United States have experienced parental incarceration. Rates of parental incarceration have increased dramatically over the past four decades. Children with an incarcerated parent (CIP) are seven times more likely to have a diagnosed substance use disorder due to…

  • The Phosphatidylethanol (PEth) Results Communication (PERC) Study

    3R34AA031652-03S1
    Judith Hahn · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA · $50,109 · awarded May 27, 2026 · NIH

    Unhealthy alcohol use is very prevalent (22-30%) among persons with HIV (PWH), impairs adherence to antiretroviral therapy (ART), and fuels inflammation, HIV non-suppression, coinfections (e.g., tuberculosis), and noncommunicable diseases (NCDs) that are common among PWH. There is an urgent need to reduce unhealthy alcohol use, especially in Uganda which…

  • Digital Screening and Brief Intervention for Perinatal Substance Use in Home Visiting

    5R34DA061238-03
    SARAH DAUBER · PARTNERSHIP TO END ADDICTION, NY · $254,414 · awarded May 26, 2026 · NIH

    Abstract The early postpartum period is a time of significant risk for escalating substance use (SU), as many people who reduce their SU during pregnancy return to pre-pregnancy levels within 3 months postpartum. Addressing postpartum SU is key to preventing negative maternal and child health outcomes, but postpartum mothers are unlikely to seek treatment…

  • Transdiagnostic Sleep and Circadian Treatment for Autistic Adolescents and Young Adults

    1R34MH141224-01
    Kristina Lenker · PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA · $704,700 · awarded May 26, 2026 · NIH

    PROJECT SUMMARY/ABSTRACT This proposal will address the critical need for evidence-based transdiagnostic sleep interventions for autistic adolescents and young adults (AYA). Autistic AYA frequently report a multitude of pervasive sleep and circadian problems, including difficulties initiating and maintaining sleep, excessive sleepiness, delayed phase, and…

  • Developing and Piloting a Supervision Strategy for Substance Use Disorder Treatment Programs

    5R34DA060419-03
    Jure Baloh · UNIV OF ARKANSAS FOR MED SCIS, AR · $214,616 · awarded May 25, 2026 · NIH

    Substance use disorders (SUDs) such as addiction to opioids, methamphetamines and alcohol are a significant burden in the US, affecting almost 50 million individuals annually. Community specialty SUD treatment programs (“SUD programs”) are a key type of SUD providers and while effective treatments for SUD exist, significant issues in the organization and…

  • AI-Facilitated Partner Communication for PrEP

    1R34MH142048-01
    Whitney Irie · BOSTON COLLEGE, MA · $736,887 · awarded May 25, 2026 · NIH

    The AI-Facilitated Partner Communication for PrEP study aims to enhance HIV prevention among women by empowering them with skills to discuss pre-exposure prophylaxis (PrEP) with male sexual partners. Existing PrEP interventions rarely address the complex barriers to partner communication that influence PrEP uptake. This R34 proposal aims to develop and…

  • PrEP-RISE: A Multi-Level PhotoVoice Intervention to Improve PrEP Uptake and Adherence Among Women Who Inject Drugs (WWID)

    1R34DA064469-01
    Suzan Walters · NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY · $256,165 · awarded May 19, 2026 · NIH

    Women who inject drugs (WWID) in the United States experience disproportionately high rates of HIV due to vulnerabilities related to drug use and sex. Despite the proven effectiveness of Pre-Exposure Prophylaxis (PrEP) in preventing HIV, its uptake among WWID remains critically low, in part due to mistrust and negative perceptions about the healthcare…

Funding institutes in the sample

InstituteAwardsFunding
NIH392$113.3M

Most frequent institutions in the sample

  1. UNIVERSITY OF MICHIGAN AT ANN ARBOR 18 awards
  2. YALE UNIVERSITY 15 awards
  3. NEW YORK UNIVERSITY SCHOOL OF MEDICINE 11 awards
  4. MASSACHUSETTS GENERAL HOSPITAL 11 awards
  5. UNIV OF NORTH CAROLINA CHAPEL HILL 10 awards
  6. DUKE UNIVERSITY 10 awards
  7. UNIVERSITY OF WASHINGTON 9 awards
  8. UNIVERSITY OF CALIFORNIA LOS ANGELES 9 awards

Source: NIH RePORTER. Verify any award in the official record by searching its project number. See our data methodology for how this sample is built and its limitations.

Decision guide

Choose R34 when

Choose R34 when you need 1–3 years to plan a multi-site or otherwise complex clinical trial.

Choose another mechanism when

R34 is not for executing trials, only for planning them.

Who applies for R34

Investigators planning a clinical trial that will be too large for direct R01 submission, or that requires upfront infrastructure design (data coordination, IRB harmonization, recruitment planning).

Compare nearby NIH grant mechanisms

Searchers often land on R34 while deciding between adjacent NIH activity codes. Compare scope, NIH staff involvement, budget scale, and applicant stage before choosing a funding opportunity.

For broad grant lookup, use the NIH grant search to find funded examples by activity code, PI, institution, and award year.

Search tips for R34

  • R34 awards often immediately precede a U01 or R01 trial implementation grant from the same PI.

Search NIH grants by activity code

Find R34-funded PIs

R34 funding trends

Related NIH grant types